Company / Net Income
Coya Therapeutics, Inc. Net Income History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$21.2M
FY2025
5-year range
-$21.2M / -$8.0M
FY2023-FY2025
Trend
-165.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from -$12M to -$21M over the past 2 years.
Based on SEC 10-K filings.
-$21M in FY2025.
Declined from -$12M to -$21M over the past 2 years.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, net income decreased 165.7% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.95 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$21.2M | -165.7% |
| FY2024 | -$8.0M | +34.8% |
| FY2023 | -$12.2M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026